What it is
In order to construct an immune diagnostic, HLA proteins must be frequently be included in a diagnostic assay. Pure has or is developing for partners diagnostic antibody-screening assays with a goal of providing a precision method for determining if anti-HLA antibodies exist in a transplant recipient and the exact HLA specificity of these antibodies. The purpose of Pure is to be the primary source of HLA for these diagnostic assays. This will allow data from center to center, and from test to test, to be compared. This will allow for comparable donor-recipient matching between centers. In addition, because the data between centers and tests can be compared, we can better conclude how to match future transplant patients.